Holen Sie sich die Stockscreener-App
19.43
0.97%
-0.19
Handel nachbörslich:
19.43
Schlusskurs vom Vortag:
$19.62
Offen:
$19.7
24-Stunden-Volumen:
1.29M
Relative Volume:
1.67
Marktkapitalisierung:
$1.59B
Einnahmen:
$305.00K
Nettoeinkommen (Verlust:
$-328.98M
KGV:
-5.0731
EPS:
-3.83
Netto-Cashflow:
$-309.60M
1W Leistung:
+2.97%
1M Leistung:
+9.10%
6M Leistung:
+25.92%
1J Leistung:
-13.64%
1-Tages-Spanne:
$19.25
$19.81
1-Wochen-Bereich:
$17.91
$19.81
52-Wochen-Spanne:
$9.90
$27.20
Viridian Therapeutics Inc Stock (VRDN) Company Profile
Firmenname
Viridian Therapeutics Inc
Sektor
Branche
Telefon
617.272.4600
Adresse
221 CRESCENT STREET, WALTHAM
Vergleichen Sie VRDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
19.43 | 1.60B | 305.00K | -328.98M | -309.60M | -3.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Fortgesetzt | Jefferies | Buy |
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | Eingeleitet | TD Cowen | Buy |
| 2024-09-11 | Bestätigt | Needham | Buy |
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-05-09 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | Eingeleitet | BTIG Research | Buy |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-17 | Eingeleitet | Wells Fargo | Overweight |
| 2023-03-30 | Eingeleitet | Stifel | Buy |
| 2022-12-19 | Eingeleitet | Cowen | Outperform |
| 2022-12-19 | Eingeleitet | Needham | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-12-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-01-25 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Viridian Therapeutics Inc Aktie (VRDN) Neueste Nachrichten
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Dividend Watch: Can Viridian Therapeutics Inc. expand its profit marginsMarket Movers & Consistent Profit Focused Trading Strategies - khodrobank.com
Insider Trends: Is Viridian Therapeutics Inc stock a good pick for beginnersJobs Report & AI Optimized Trade Strategies - khodrobank.com
Will Viridian Therapeutics Inc benefit from geopolitical trendsJuly 2025 EndofMonth & High Win Rate Trade Tips - khodrobank.com
VIX Spike: Should I hold or sell Viridian Therapeutics Inc nowTrade Ideas & Consistent Return Investment Signals - khodrobank.com
Aug Big Picture: What is Viridian Therapeutics Incs 5 year growth outlookEarnings Recap Report & AI Enhanced Trading Signals - khodrobank.com
Quarterly Trades: Will Viridian Therapeutics Inc benefit from geopolitical trendsWeekly Trend Summary & Fast Entry Momentum Alerts - khodrobank.com
VIX Spike: What is Viridian Therapeutics Incs 5 year growth outlookSwing Trade & Technical Pattern Based Signals - khodrobank.com
Detecting support and resistance levels for Viridian Therapeutics Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Viridian Therapeutics Inc. stock prediction for this weekWeekly Stock Summary & Community Consensus Stock Picks - newser.com
Risk Analysis: What is the target price for Viridian Therapeutics Inc stockPrice Action & Reliable Breakout Forecasts - خودرو بانک
Published on: 2025-09-17 20:01:22 - khodrobank.com
Does Viridian Therapeutics Inc. qualify in momentum factor screeningQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
Hedge Fund Bets: What is CGONs 5 year growth outlookSwing Trade & Fast Entry High Yield Stock Tips - خودرو بانک
Aug Wrap: Should I add Viridian Therapeutics Inc. stock to my portfolio2025 Bull vs Bear & Proven Capital Preservation Methods - خودرو بانک
BTIG reiterates Buy rating on Viridian Therapeutic stock as trials complete enrollment - Investing.com Canada
Breakouts Watch: Can Viridian Therapeutics Inc withstand a market correctionWeekly Investment Recap & Fast Gain Stock Tips - khodrobank.com
Decliners Report: Can Viridian Therapeutics Inc. disrupt its industry2025 Stock Rankings & Low Risk High Reward Trade Ideas - khodrobank.com
Viridian Therapeutics, Inc. $VRDN Shares Sold by Alliancebernstein L.P. - MarketBeat
Weekly Recap: What are the future prospects of Viridian Therapeutics IncJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Viridian Therapeutics: Promising Pipeline and Strategic Advancements Justify Buy Rating - TipRanks
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates - BioSpace
Entry Recap: Can Viridian Therapeutics Inc. lead its sector in growthQuarterly Investment Review & Expert Approved Momentum Trade Ideas - khodrobank.com
Momentum Shift: Is BCGWW undervalued by DCF analysisJuly 2025 Reactions & Low Drawdown Momentum Ideas - خودرو بانک
Published on: 2025-09-15 21:50:00 - khodrobank.com
Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003 - Ophthalmology Times
Viridian Therapeutics announces completion of enrollment in both Reveal clinical trials and positive portfolio updates - MarketScreener
Viridian Therapeutics Announces Completion Of Enrollment In Both Reveal Clinical Trials And Positive Portfolio Updates - TradingView
Viridian Therapeutics (VRDN) Completes Enrollment for Key Phase 3 Trials - GuruFocus
Octagon Capital Advisors LP Reduces Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Exome Asset Management LLC Invests $2.93 Million in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Yiheng Capital Management L.P. Cuts Stock Position in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Adage Capital Partners GP L.L.C. Sells 555,414 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat
Invesco Ltd. Acquires 14,672 Shares of Viridian Therapeutics, Inc. $VRDN - MarketBeat
Viridian Therapeutics Inc. Approaches Support With Recovery in SightMarket Risk Analysis & Accurate Trade Setup Notifications - beatles.ru
Can Viridian Therapeutics Inc. lead its sector in growthMarket Weekly Review & Low Drawdown Investment Strategies - 뉴스영
Panagora Asset Management Inc. Grows Position in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Key External Factors That Drive Viridian Therapeutics Inc. Stock Price MovementsJobs Report & Smart Swing Trading Alerts - Newser
Will breakout in Viridian Therapeutics Inc. lead to full recoveryEarnings Recap Summary & Consistent Return Investment Signals - Newser
Is a relief rally coming for Viridian Therapeutics Inc. holdersEarnings Miss & High Return Trade Opportunity Guides - Newser
Will Viridian Therapeutics Inc. stock go up in YEARBull Run & Smart Swing Trading Alerts - خودرو بانک
Rafferty Asset Management LLC Reduces Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Pattern recognition hints at Viridian Therapeutics Inc. upsideSwing Trade & Real-Time Volume Triggers - Newser
Paradigm Biocapital Advisors LP Boosts Holdings in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Will Viridian Therapeutics Inc. outperform during market ralliesQuarterly Earnings Summary & Verified Momentum Watchlists - خودرو بانک
Will Viridian Therapeutics Inc. rebound enough to break evenPortfolio Gains Report & Step-by-Step Trade Execution Guides - Newser
Technical analysis overview for Viridian Therapeutics Inc. stock2025 Year in Review & Smart Allocation Stock Reports - Newser
How to use Fibonacci retracement on Viridian Therapeutics Inc.Weekly Market Report & AI Enhanced Trade Execution Alerts - Newser
How to forecast Viridian Therapeutics Inc. trends using time seriesQuarterly Profit Report & Risk Managed Investment Strategies - Newser
Can you recover from losses in Viridian Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
Will Viridian Therapeutics Inc. bounce back from current supportJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):